Interview with Dr. Andrew Cutler

Dr. Andrew J. Cutler shares his insights on the current challenges and opportunities for CNS therapies during an energizing conversation with Dr. Mark Opler, Chief Research Officer at WCG MedAvante-ProPhase.

Dr. Cutler is a member of WCG’s Scientific Leadership Team, and a recognized expert in CNS therapies and clinical trials. Dr. Cutler is a sought-after speaker about the evaluation and treatment of mental illnesses such as ADHD, Bipolar Disorder (Manic-Depression), Major Depression, Anxiety Disorders and Schizophrenia. He conducts clinical trials for Phase I-IV studies. Indications include ADHD in children, adolescents and adults, depression, anxiety, bipolar disorder, schizophrenia and other neuropsychiatric and medical conditions. In addition to being the Chief Medical Officer for Meridien Research, Dr. Cutler is a Courtesy Assistant Professor of Psychiatry at the University of Florida.

Read Dr. Cutler's full bio.

About the Author

Dr. Mark Opler, PhD, MPH | Chief Research Officer

Dr. Mark Opler serves as Chief Research Officer, directing scientific research and development at MedAvante-ProPhase. Dr. Opler was the founder of ProPhase and served as its CEO and Chief Scientific Officer among other positions. He holds the titles of Adjunct Assistant Professor of Psychiatry at New York University and Assistant Professor of Clinical Neuroscience at Columbia University’s College of Physicians and Surgeons. His academic research focuses on the etiology, phenomenology, and treatment of serious and persistent mental disorders. He is also leading the development of the new upcoming edition of the PANSS Manual©.

Follow on Linkedin More Content by Dr. Mark Opler, PhD, MPH | Chief Research Officer
Previous Flipbook
The 4 Data-Driven Archetypes
The 4 Data-Driven Archetypes

Biopharmaceutical organizations recognize the extraordinary power of data but vary significantly in how the...

Next Flipbook
Q&A with CNS Expert, Dr. Philip Scheltens
Q&A with CNS Expert, Dr. Philip Scheltens

Philip Scheltens, MD, PhD, a member of WCG’s Scientific Leadership Team, shared his insights during a recen...